← All Onconetix, INC filings

Onconetix, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
ONCO
Onconetix, INC
SCHEDULE: Onconetix Stakeholder Discloses 6.1% Ownership
Keystone Capital Partners, RANZ Group, and Fredric Zaino have jointly filed a Schedule 13G, reporting beneficial ownership of 223,717 shares of Onconetix, Inc. common stock, representing 6.1% of the outstanding shares.
NASDAQ
ONCO
Onconetix, INC
SCHEDULE 13G/A: American Financial Group Discloses Passive 0.0% Stake in ONCONETIX, INC.
American Financial Group, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 36,023 common shares, representing 0.0% of ONCONETIX, INC.
NASDAQ
ONCO
Onconetix, INC
SCHEDULE 13G/A: Zurcher Kantonalbank Discloses 2.5% Passive Stake in Onconetix, Inc.
Zurcher Kantonalbank (Zurich Cantonalbank) has filed an amended Schedule 13G, reporting a passive beneficial ownership of 2.5% in Onconetix, Inc.'s common stock as of December 24, 2024.